AMSTERDAM - Tuesday, March 10th 2015 [ME NewsWire]
(BUSINESS WIRE) -- Regulatory News:
Pershing Square Holdings, Ltd. (ticker: PSH:NA) announced today a new position in Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) representing approximately 16.9% of the PSH portfolio (based on the closing NAV of PSH and the closing share price of VRX on Friday, 6 March 2015).
Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd., announced that various funds it manages have purchased 16,473,933 shares of Valeant Pharmaceuticals International, Inc., representing 4.9% of Valeant.
About Pershing Square Holdings, Ltd.
Pershing Square Holdings, Ltd. is a concentrated, research‐intensive, fundamental value investor in the public markets.
Tim Burt, +44 (0)20 7240 2486